Comment: This anti-ILT7 antibody is claimed in patent US8084585 [
1], in which it is isolated from hybridoma ILT7#11. It was developed as a novel therapeutic for the treatment of autoimmune condtions. Note that ILT7 is interchangeable with the official gene symbol LILRA4.
